{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:26:22Z","timestamp":1787019982482,"version":"build-2736575974"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T00:00:00Z","timestamp":1765584000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T00:00:00Z","timestamp":1766966400000},"content-version":"vor","delay-in-days":16,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Ophthal Inflamm Infect"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>To analyze the distribution of intermediate uveitis (IU) etiologies by age in order to guide the diagnostic approach.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a monocentric retrospective study of 126 adult patients referred to an internal medicine department at a tertiary center with a diagnosis of intermediate uveitis of unknown cause between July 2002 and April 2023.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Among the 126 patients, most were women (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200977; 61%), with a median age of 49 [33;62] years; 113 (90%) were Caucasian. Idiopathic IU was the most common etiology across all age groups. In patients under 30 years old (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200920), idiopathic IU was observed in 10 cases (50%), followed by pars planitis in 7 cases (35%) and multiple sclerosis in 2 cases (10%). In the 30\u201360-year group (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200971), idiopathic IU remained the most frequent (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200934, 48%), followed by sarcoidosis (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200915, 21%) and lymphoma (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u20095, 7%). Other etiologies included pars planitis (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u20093), multiple sclerosis (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u20093), and infections (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u20092). After 60 years (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200935), idiopathic IU was again the most prevalent (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200922, 63%), followed by lymphoma (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u20096, 17%) and sarcoidosis (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u20095, 14%). Infectious diseases were observed in 2 cases.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The etiologic distribution of IU varies with age. Before 30, idiopathic IU, pars planitis, and multiple sclerosis are the most common etiologies. After 30, idiopathic IU, sarcoidosis, and lymphoma become more prevalent, with lymphoma appearing after 45. After 60, lymphoma is more common than sarcoidosis. These findings support the use of an age-stratified diagnostic approach in the evaluation of IU.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12348-025-00563-w","type":"journal-article","created":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T08:05:04Z","timestamp":1765613104000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Etiologies of intermediate uveitis in a tertiary center: an age-oriented medical assessment?"],"prefix":"10.1186","volume":"15","author":[{"given":"P.","family":"Mansuy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"El-Jammal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Jacquot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Mathis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Kodjikian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascal","family":"S\u00e8ve","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,13]]},"reference":[{"key":"563_CR1","doi-asserted-by":"publisher","unstructured":"Standardization of Uveitis Nomenclature for Reporting Clinical Data (2005) Results of the First International Workshop. Am J Ophthalmol 140:509\u2013516. https:\/\/doi.org\/10.1016\/j.ajo.2005.03.057. PMID: 16196117","DOI":"10.1016\/j.ajo.2005.03.057"},{"key":"563_CR2","doi-asserted-by":"publisher","unstructured":"Teo AYT, Betzler BK, Hua KLQ, Chen EJ, Gupta V, Agrawal R (2023) Intermediate uveitis: a review. Ocul Immunol Inflamm 31:1041\u20131060. https:\/\/doi.org\/10.1080\/09273948.2022.2070503. PMID: 35759636","DOI":"10.1080\/09273948.2022.2070503"},{"key":"563_CR3","doi-asserted-by":"publisher","first-page":"127","DOI":"10.3899\/jrheum.080102","volume":"36","author":"E Jakob","year":"2009","unstructured":"Jakob E, Reuland MS, Mackensen F, Harsch N, Fleckenstein M, Lorenz H-M, Max R, Becker MD (2009) Uveitis subtypes in a German interdisciplinary uveitis Center\u2014Analysis of 1916 patients. J Rheumatol 36:127\u2013136. https:\/\/doi.org\/10.3899\/jrheum.080102","journal-title":"J Rheumatol"},{"key":"563_CR4","doi-asserted-by":"publisher","first-page":"118","DOI":"10.3109\/09273948.2013.855799","volume":"23","author":"NP Jones","year":"2015","unstructured":"Jones NP (2015) The Manchester uveitis clinic: the first 3000 Patients\u2014Epidemiology and casemix. Ocul Immunol Inflamm 23:118\u2013126. https:\/\/doi.org\/10.3109\/09273948.2013.855799","journal-title":"Ocul Immunol Inflamm"},{"key":"563_CR5","doi-asserted-by":"publisher","first-page":"346","DOI":"10.3109\/09273948.2014.1002567","volume":"23","author":"RS Grajewski","year":"2015","unstructured":"Grajewski RS, Caramoy A, Frank KF, Rubbert-Roth A, F\u00e4tkenheuer G, Kirchhof B, Cursiefen C, Heindl LM (2015) Spectrum of uveitis in A German tertiary center: review of 474 consecutive patients. Ocul Immunol Inflamm 23:346\u2013352. https:\/\/doi.org\/10.3109\/09273948.2014.1002567","journal-title":"Ocul Immunol Inflamm"},{"key":"563_CR6","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/s13023-017-0638-9","volume":"12","author":"T Ness","year":"2017","unstructured":"Ness T, Boehringer D, Heinzelmann S (2017) Intermediate uveitis: pattern of etiology, complications, treatment and outcome in a tertiary academic center. Orphanet J Rare Dis 12:81. https:\/\/doi.org\/10.1186\/s13023-017-0638-9Cited: in:: PMID: 28449695","journal-title":"Orphanet J Rare Dis"},{"key":"563_CR7","volume-title":"Oeil et maladies syst\u00e9miques","author":"P S\u00e8ve","year":"2013","unstructured":"S\u00e8ve P, Kodjikan L (2013) Oeil et maladies syst\u00e9miques. M\u00e9decine sciences, Paris"},{"key":"563_CR8","doi-asserted-by":"publisher","unstructured":"Biju Mark J, Smit DP, Sr ER (2025) Intermediate uveitis: an updated review of the differential diagnosis and relevant special investigations. Ocul Immunol Inflamm 33:522\u2013534. https:\/\/doi.org\/10.1080\/09273948.2025.2450473","DOI":"10.1080\/09273948.2025.2450473"},{"key":"563_CR9","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.ajo.2021.03.045","volume":"228","author":"Classification Criteria For Pars Planitis","year":"2021","unstructured":"Classification Criteria For Pars Planitis (2021) Am J Ophthalmol 228:268\u2013274. https:\/\/doi.org\/10.1016\/j.ajo.2021.03.045","journal-title":"Am J Ophthalmol"},{"key":"563_CR10","doi-asserted-by":"publisher","first-page":"469","DOI":"10.4103\/2008-322X.176897","volume":"10","author":"P Ozdal","year":"2015","unstructured":"Ozdal P, Berker N, Tugal-Tutkun I (2015) Pars planitis: Epidemiology, clinical characteristics, management and visual prognosis. J Ophthalmic Vis Res 10:469. https:\/\/doi.org\/10.4103\/2008-322X.176897","journal-title":"J Ophthalmic Vis Res"},{"key":"563_CR11","doi-asserted-by":"publisher","first-page":"102351","DOI":"10.1016\/j.autrev.2019.102351","volume":"18","author":"P-J Bertrand","year":"2019","unstructured":"Bertrand P-J, Jamilloux Y, Ecochard R, Richard-Colmant G, Gerfaud-Valentin M, Guillaud M, Denis P, Kodjikian L, S\u00e8ve P (2019) Uveitis: Autoimmunity\u2026 and beyond. Autoimmun Rev 18:102351. https:\/\/doi.org\/10.1016\/j.autrev.2019.102351","journal-title":"Autoimmun Rev"},{"key":"563_CR12","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.ajo.2017.03.029","volume":"178","author":"A De Parisot","year":"2017","unstructured":"De Parisot A, Kodjikian L, Errera M-H, Sedira N, Heron E, P\u00e9rard L, Cornut P-L, Schneider C, Rivi\u00e8re S, Oll\u00e9 P et al (2017) Randomized controlled trial evaluating a standardized strategy for uveitis etiologic diagnosis (ULISSE). Am J Ophthalmol 178:176\u2013185. https:\/\/doi.org\/10.1016\/j.ajo.2017.03.029","journal-title":"Am J Ophthalmol"},{"key":"563_CR13","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1136\/bmj.2.5261.1165","volume":"2","author":"JG Scadding","year":"1961","unstructured":"Scadding JG (1961) Prognosis of intrathoracic sarcoidosis in England. BMJ 2:1165\u20131172. https:\/\/doi.org\/10.1136\/bmj.2.5261.1165","journal-title":"BMJ"},{"key":"563_CR14","doi-asserted-by":"publisher","unstructured":"Borciuch C, El-Jammal T, Kodjikian L, Boussel L, Romain-Scelle N, Nourredine M, Gerfaud-Valentin M, S\u00e8ve P (2024) Value of chest X-ray and chest computed tomography for systemic sarcoidosis diagnosis in undifferentiated uveitis. Ocul Immunol Inflamm 32:161\u2013167. https:\/\/doi.org\/10.1080\/09273948.2023.2226203. PMID: 37364057","DOI":"10.1080\/09273948.2023.2226203"},{"key":"563_CR15","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1055\/s-0040-1710536","volume":"41","author":"P S\u00e8ve","year":"2020","unstructured":"S\u00e8ve P, Jamilloux Y, Tilikete C, Gerfaud-Valentin M, Kodjikian L, El Jammal T (2020) Ocular sarcoidosis. Semin Respir Crit Care Med 41:673\u2013688. https:\/\/doi.org\/10.1055\/s-0040-1710536","journal-title":"Semin Respir Crit Care Med"},{"key":"563_CR16","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/S1474-4422(17)30470-2","volume":"17","author":"AJ Thompson","year":"2018","unstructured":"Thompson AJ, Banwell BL, Barkhof F, Carroll WM, Coetzee T, Comi G, Correale J, Fazekas F, Filippi M, Freedman MS et al (2018) Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol 17:162\u2013173. https:\/\/doi.org\/10.1016\/S1474-4422(17)30470-2Cited: in:: PMID: 29275977","journal-title":"Lancet Neurol"},{"key":"563_CR17","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1177\/1120672119856943","volume":"30","author":"A Bernard","year":"2020","unstructured":"Bernard A, Seve P, Abukhashabh A, Roure-Sobas C, Boibieux A, Denis P, Broussolle C, Mathis T, Kodjikian L (2020) Lyme-associated uveitis: clinical spectrum and review of literature. Eur J Ophthalmol 30:874\u2013885. https:\/\/doi.org\/10.1177\/1120672119856943","journal-title":"Eur J Ophthalmol"},{"key":"563_CR18","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1080\/09273948.2019.1653933","volume":"28","author":"R Agrawal","year":"2020","unstructured":"Agrawal R, Agarwal A, Jabs DA, Kee A, Testi I, Mahajan S, McCluskey PJ, Gupta A, Palestine A, Denniston A et al (2020) Standardization of nomenclature for ocular tuberculosis - Results of collaborative ocular tuberculosis study (COTS) workshop. Ocul Immunol Inflamm 28:74\u201384 Cited: in:: PMID: 31821096","journal-title":"Ocul Immunol Inflamm"},{"key":"563_CR19","doi-asserted-by":"publisher","DOI":"10.1007\/s10792-016-0434-x","author":"C Luca","year":"2017","unstructured":"Luca C, Raffaella A, Sylvia M, Valentina M, Fabiana V, Marco C, Annamaria S, Luisa S, Alessandro DF, Lucia B et al (2017) Changes in patterns of uveitis at a tertiary referral center in Northern italy: analysis of 990 consecutive cases. Int Ophthalmol [Internet]. https:\/\/doi.org\/10.1007\/s10792-016-0434-x. [cited 2024 Sep 30]","journal-title":"Int Ophthalmol [Internet]"},{"key":"563_CR20","doi-asserted-by":"publisher","first-page":"337","DOI":"10.3906\/sag-1302-132","volume":"44","author":"MP \u00c7akar \u00d6zdal","year":"2014","unstructured":"\u00c7akar \u00d6zdal MP, Yazici A, T\u00fcfek M, \u00d6zt\u00fcrk F (2014) Epidemiology of uveitis in a referral hospital in Turkey. Turk J Med Sci 44:337\u2013342. https:\/\/doi.org\/10.3906\/sag-1302-132","journal-title":"Turk J Med Sci"},{"key":"563_CR21","doi-asserted-by":"publisher","first-page":"S69","DOI":"10.3109\/09273948.2015.1133839","volume":"25","author":"MZA Win","year":"2017","unstructured":"Win MZA, Win T, Myint S, Shwe T, Sandar H (2017) Epidemiology of uveitis in a tertiary eye center in Myanmar. Ocul Immunol Inflamm 25:S69\u2013S74. https:\/\/doi.org\/10.3109\/09273948.2015.1133839","journal-title":"Ocul Immunol Inflamm"},{"key":"563_CR22","doi-asserted-by":"publisher","first-page":"S75","DOI":"10.1080\/09273948.2017.1335755","volume":"25","author":"JM Aba\u00f1o","year":"2017","unstructured":"Aba\u00f1o JM, Galvante PR, Siopongco P, Dans K, Lopez J (2017) Review of epidemiology of uveitis in asia: pattern of uveitis in a tertiary hospital in the Philippines. Ocul Immunol Inflamm 25:S75\u2013S80. https:\/\/doi.org\/10.1080\/09273948.2017.1335755","journal-title":"Ocul Immunol Inflamm"},{"key":"563_CR23","doi-asserted-by":"publisher","first-page":"311","DOI":"10.3109\/09273948.2014.939197","volume":"23","author":"H Al Dhahri","year":"2015","unstructured":"Al Dhahri H, Al Rubaie K, Hemachandran S, Mousa A, Gikandi PW, Al-Mezaine HS, Abu El-Asrar AM (2015) Patterns of uveitis in a University-based tertiary referral center in Riyadh, Saudi Arabia. Ocul Immunol Inflamm 23:311\u2013319. https:\/\/doi.org\/10.3109\/09273948.2014.939197","journal-title":"Ocul Immunol Inflamm"},{"key":"563_CR24","doi-asserted-by":"publisher","unstructured":"Barisani-Asenbauer T, Maca SM, Mejdoubi L, Emminger W, Machold K, Auer H (2012) Uveitis-a rare disease often associated with systemic diseases and infections-a systematic review of 2619 patients. Orphanet J Rare Dis 7:57. https:\/\/doi.org\/10.1186\/1750-1172-7-57. PMID: 22932001","DOI":"10.1186\/1750-1172-7-57"},{"key":"563_CR25","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1097\/00005792-200107000-00005","volume":"80","author":"B Bodaghi","year":"2001","unstructured":"Bodaghi B, Cassoux N, Wechsler B, Hannouche D, Fardeau C, Papo T, Huong DLT, Piette J-C, Lehoang P (2001) Chronic severe uveitis: etiology and visual outcome in 927 patients from a single center. Medicine 80:263\u2013270. https:\/\/doi.org\/10.1097\/00005792-200107000-00005","journal-title":"Medicine"},{"key":"563_CR26","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.ajo.2021.03.052","volume":"228","author":"DA Jabs","year":"2021","unstructured":"Jabs DA, Acharya NR, Chee S-P, Goldstein D, McCluskey P, Murray PI, Oden N, Palestine AG, Rosenbaum JT, Thorne JE et al (2021) Classification criteria for Fuchs uveitis syndrome. Am J Ophthalmol 228:262\u2013267. https:\/\/doi.org\/10.1016\/j.ajo.2021.03.052","journal-title":"Am J Ophthalmol"},{"key":"563_CR27","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.ajo.2021.03.059","volume":"228","author":"DA Jabs","year":"2021","unstructured":"Jabs DA, Brezin AP, Levinson RD, McCluskey P, Oden N, Palestine AG, Read RW, Thorne JE, Trusko BE, Vitale A et al (2021) Classification criteria for birdshot chorioretinitis. Am J Ophthalmol 228:65\u201371. https:\/\/doi.org\/10.1016\/j.ajo.2021.03.059","journal-title":"Am J Ophthalmol"},{"key":"563_CR28","doi-asserted-by":"publisher","first-page":"535","DOI":"10.2165\/00002512-200623070-00001","volume":"23","author":"R Gupta","year":"2006","unstructured":"Gupta R, Murray PI (2006) Chronic Non-Infectious uveitis in the elderly: Epidemiology, pathophysiology and management. Drugs Aging 23:535\u2013558. https:\/\/doi.org\/10.2165\/00002512-200623070-00001","journal-title":"Drugs Aging"},{"key":"563_CR29","doi-asserted-by":"publisher","first-page":"1971","DOI":"10.1007\/s00417-019-04411-1","volume":"257","author":"P Grumet","year":"2019","unstructured":"Grumet P, Kerever S, Gilbert T, Kodjikian L, Gerfaud-Valentin M, De Parisot A, Jamilloux Y, S\u00e8ve P (2019) Clinical and etiologic characteristics of de Novo uveitis in patients aged 60 years and above: experience of a French tertiary center. Graefes Arch Clin Exp Ophthalmol 257:1971\u20131979. https:\/\/doi.org\/10.1007\/s00417-019-04411-1","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"563_CR30","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1055\/s-2008-1035548","volume":"204","author":"C Favre","year":"1994","unstructured":"Favre C, Tran V, Herbort C (1994) Uv\u00e9ite de La personne \u00e2g\u00e9e. Klin Monatsbl Augenheilkd 204:319\u2013322. https:\/\/doi.org\/10.1055\/s-2008-1035548","journal-title":"Klin Monatsbl Augenheilkd"},{"key":"563_CR31","doi-asserted-by":"publisher","first-page":"219","DOI":"10.3109\/09273948.2011.580071","volume":"19","author":"M-A Gr\u00e9goire","year":"2011","unstructured":"Gr\u00e9goire M-A, Kodjikian L, Varron L, Grange J-D, Broussolle C, Seve P (2011) Characteristics of uveitis presenting for the first time in the elderly: analysis of 91 patients in a tertiary center. Ocul Immunol Inflamm 19:219\u2013226. https:\/\/doi.org\/10.3109\/09273948.2011.580071","journal-title":"Ocul Immunol Inflamm"},{"key":"563_CR32","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.1007\/s10792-021-01721-4","volume":"41","author":"S Shirahama","year":"2021","unstructured":"Shirahama S, Soga H, Tanaka R, Fukunaga H, Izawa H, Komae K, Nakahara H, Kawashima H, Aihara M, Kaburaki T (2021) Clinical features of uveitis in elderly patients in central Tokyo (2013\u20132018). Int Ophthalmol 41:1671\u20131679. https:\/\/doi.org\/10.1007\/s10792-021-01721-4","journal-title":"Int Ophthalmol"},{"key":"563_CR33","doi-asserted-by":"publisher","unstructured":"Primary vitreoretinal lymphoma\u2014a review (2017) Asia Pac J Ophthalmol (Phila) [Internet]. [cited 2025 Nov 15]. https:\/\/doi.org\/10.22608\/APO.2017150","DOI":"10.22608\/APO.2017150"},{"key":"563_CR34","doi-asserted-by":"publisher","unstructured":"Chan C-C, Rubenstein JL, Coupland SE, Davis JL, Harbour JW, Johnston PB, Cassoux N, Touitou V, Smith JR, Batchelor TT et al (2011) Primary vitreoretinal lymphoma: A report from an international primary central nervous system lymphoma collaborative group symposium. Oncologist 16:1589\u20131599. https:\/\/doi.org\/10.1634\/theoncologist.2011-0210","DOI":"10.1634\/theoncologist.2011-0210"},{"key":"563_CR35","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.1093\/annonc\/mdm340","volume":"18","author":"SA Grimm","year":"2007","unstructured":"Grimm SA, Pulido JS, Jahnke K, Schiff D, Hall AJ, Shenkier TN, Siegal T, Doolittle ND, Batchelor T, Herrlinger U et al (2007) Primary intraocular lymphoma: an international primary central nervous system lymphoma collaborative group report. Ann Oncol 18:1851\u20131855. https:\/\/doi.org\/10.1093\/annonc\/mdm340","journal-title":"Ann Oncol"},{"key":"563_CR36","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.ajo.2021.03.047","volume":"228","author":"DA Jabs","year":"2021","unstructured":"Jabs DA, Acharya NR, Denniston AK, Lightman SL, McCluskey P, Oden N, Okada AA, Palestine AG, Thorne JE, Trusko BE et al (2021) Classification criteria for Sarcoidosis-Associated uveitis. Am J Ophthalmol 228:220\u2013230. https:\/\/doi.org\/10.1016\/j.ajo.2021.03.047","journal-title":"Am J Ophthalmol"},{"key":"563_CR37","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.ajo.2021.03.044","volume":"228","author":"Classification Criteria for Multiple Sclerosis-Associated Intermediate Uveitis","year":"2021","unstructured":"Classification Criteria for Multiple Sclerosis-Associated Intermediate Uveitis (2021) Am J Ophthalmol 228:72\u201379. https:\/\/doi.org\/10.1016\/j.ajo.2021.03.044","journal-title":"Am J Ophthalmol"},{"key":"563_CR38","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1080\/09273948.2021.1898001","volume":"29","author":"S Touhami","year":"2021","unstructured":"Touhami S, Leclercq M, Stanescu-Segall D, Touitou V, Bodaghi B (2021) Differential diagnosis of vitritis in adult patients. Ocul Immunol Inflamm 29:786\u2013795. https:\/\/doi.org\/10.1080\/09273948.2021.1898001","journal-title":"Ocul Immunol Inflamm"},{"key":"563_CR39","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1007\/s00417-005-0138-9","volume":"244","author":"K Jahnke","year":"2006","unstructured":"Jahnke K, Korfel A, Komm J, Bechrakis NE, Stein H, Thiel E, Coupland SE (2006) Intraocular lymphoma 2000\u20132005: results of a retrospective multicentre trial. Graefe\u2019s Arch Clin Exp Ophthalmo 244:663\u2013669. https:\/\/doi.org\/10.1007\/s00417-005-0138-9","journal-title":"Graefe\u2019s Arch Clin Exp Ophthalmo"},{"key":"563_CR40","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1136\/bjo.2010.194514","volume":"96","author":"A Rahmi","year":"2012","unstructured":"Rahmi A, Deshayes E, Maucort-Boulch D, Varron L, Grange JD, Kodjikian L, Seve P (2012) Intraocular sarcoidosis: association of clinical characteristics of uveitis with findings from18 F-labelled Fluorodeoxyglucose positron emission tomography. Br J Ophthalmol 96:99\u2013103. https:\/\/doi.org\/10.1136\/bjo.2010.194514","journal-title":"Br J Ophthalmol"},{"key":"563_CR41","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.1136\/bjophthalmol-2018-313133","volume":"103","author":"P Chauvelot","year":"2019","unstructured":"Chauvelot P, Skanjeti A, Jamilloux Y, De Parisot A, Broussolle C, Denis P, Ramackers JM, Giammarile F, Kodjikian L, Seve P (2019) 18 F-fluorodeoxyglucose positron emission tomography is useful for the diagnosis of intraocular sarcoidosis in patients with a normal CT scan. Br J Ophthalmol 103:1650\u20131655. https:\/\/doi.org\/10.1136\/bjophthalmol-2018-313133","journal-title":"Br J Ophthalmol"},{"key":"563_CR42","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1080\/09273948.2020.1870145","volume":"30","author":"N Chirpaz","year":"2022","unstructured":"Chirpaz N, Md KS, Md PD, Gavoille A, Md, Kodjikian L, Md PD, Bernier R, Md, Gerfaud-Valentin M, Md DP, Md PD, Mathis T, Md PD, Jamilloux Y, Md PD, S\u00e8ve P, Md PD (2022) Relevance of brain MRI in patients with uveitis: retrospective cohort on 402 patients. Ocul Immunol Inflamm 30:1109\u20131115. https:\/\/doi.org\/10.1080\/09273948.2020.1870145","journal-title":"Ocul Immunol Inflamm"},{"key":"563_CR43","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1097\/IAE.0000000000001922","volume":"38","author":"C Pochat-Cotilloux","year":"2018","unstructured":"Pochat-Cotilloux C, Bienvenu J, Nguyen A-M, Ohanessian R, Ghesqui\u00e8res H, S\u00e8ve P, Garnier L, Kodjikian L (2018) Use of a threshold of interleukin-10 and IL-10\/IL-6 ratio in ocular samples for the screening of vitreoretinal lymphoma. Retina 38:773\u2013781. https:\/\/doi.org\/10.1097\/IAE.0000000000001922","journal-title":"Retina"},{"key":"563_CR44","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1016\/j.autrev.2017.10.010","volume":"16","author":"P S\u00e8ve","year":"2017","unstructured":"S\u00e8ve P, Cacoub P, Bodaghi B, Trad S, Sellam J, Bellocq D, Bielefeld P, S\u00e8ne D, Kaplanski G, Monnet D et al (2017) Uveitis: diagnostic work-up. A literature review and recommendations from an expert committee. Autoimmun Rev 16:1254\u20131264. https:\/\/doi.org\/10.1016\/j.autrev.2017.10.010","journal-title":"Autoimmun Rev"},{"key":"563_CR45","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1016\/S0002-9394(00)00659-0","volume":"130","author":"DA Jabs","year":"2000","unstructured":"Jabs DA, Rosenbaum JT, Foster CS, Holland GN, Jaffe GJ, Louie JS, Nussenblatt RB, Stiehm ER, Tessler H, Van Gelder RN et al (2000) Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: recommendations of an expert panel. Am J Ophthalmol 130:492\u2013513. https:\/\/doi.org\/10.1016\/S0002-9394(00)00659-0","journal-title":"Am J Ophthalmol"}],"container-title":["Journal of Ophthalmic Inflammation and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12348-025-00563-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12348-025-00563-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12348-025-00563-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T16:28:57Z","timestamp":1781627337000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12348-025-00563-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,13]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["563"],"URL":"https:\/\/doi.org\/10.1186\/s12348-025-00563-w","relation":{},"ISSN":["1869-5760"],"issn-type":[{"value":"1869-5760","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,13]]},"assertion":[{"value":"10 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study received approval from the local ethics committee in February 2019 (No. 19\u201331) and was registered on ClinicalTrials.gov (NCT03877575). All participants provided informed consent for the use of their anonymized clinical data.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"97"}}